Alireza Zali

Alireza Zali

Auto-generated profile, based on publicly available information

Alireza Zali

Functional Neurosurgery Research Center, Research Institute of Functional Neurosurgery, Shohada Tajrish Comprehensive Neurosurgical Center of Excellence, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2023 in Frontiers in Surgery
Verified
Journal Article
Open access
KKKimia Kazemzadeh
Kimia Kazemzadeh
MAMeisam Akhlaghdoust
Meisam Akhlaghdoust
AZAlireza Zali
Alireza Zali
Neurosurgical practitioners undergo extensive and prolonged training to acquire diverse technical proficiencies, while neurosurgical procedures necessitate a substantial amount of pre-, post-, and intraoperative clinical data acquisition, making decisions, attention, and convalescence. The past decade witnessed an appreciable escalation in the significance of artificial intelligence (AI) in neurosurgery. AI holds significant potential in neurosurgery as it supplements the abilities of neurosurgeons to offer optimal interventional and non-interventional care to patients by improving prognostic and diagnostic outcomes in clinical therapy and assisting neurosurgeons in making decisions while surgical interventions to enhance patient outcomes. Other technologies including augmented reality, robotics, and virtual reality can assist and promote neurosurgical methods as well. Moreover, they play a significant role in generating, processing, as well as storing experimental and clinical data. Also, the usage of these technologies in neurosurgery is able to curtail the number of costs linked with surgical care and extend high-quality health care to a wider populace. This narrative review aims to integrate the results of articles that elucidate the role of the aforementioned technologies in neurosurgery.

1 October 2020 in Immunologic Research
Verified
Journal Article
Open access
PDF file
Daniela CalinaDaniela Calina
Daniela Calina
CSChandan Sarkar
Chandan Sarkar
Andreea Letitia ArseneAndreea Letitia Arsene
Andreea Letitia Arsene
BSBahare Salehi
Bahare Salehi
Anca Oana DoceaAnca Oana Docea
Anca Oana Docea
Javad Sharifi-RadJavad Sharifi-Rad
Javad Sharifi-Rad
During the COVID-19 pandemic in a modern era, there is a global consensus on the need for the rapid development of a vaccine against SARS-CoV-2 for effective and sustainable control. Developing these vaccines is fundamental to public health. This urgent need is supported by the scientific explosion in structural and genomic biology that facilitates the urgent development of an ideal COVID-19 vaccine, using new pathways to facilitate its large-scale development, testing, and manufacture. Here, we summarize the types of COVID-19 candidate vaccines, their current stage in early testing in human clinical trials, and the challenges for their implementation.

7 November 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AZAlireza Zali
Alireza Zali
MKMahmood Khodadoost
Mahmood Khodadoost
SGSaeid Gholamzadeh
Saeid Gholamzadeh
SJShahriar Janbazi
Shahriar Janbazi
HPHassan Piri
Hassan Piri
GMGohar Mohammadi
Gohar Mohammadi
The aim of this study was to evaluate the death proportion and death risk of COVID-19 hospitalized patients over time and in different surges of COVID-19. This multi-center observational study was conducted from March 21, 2021 to October 3, 2021 which included the alpha and delta SARS-CoV-2 surges occurred in April and August in Tehran, respectively. The risk of COVID-19 death was compared in different months of admission. A total of 270,624 patients with COVID-19, of whom 6.9% died, were admitted to hospitals in Tehran province. Compared to patients admitted in March, a higher risk of COVID-19 death was observed among patients admitted to the hospital in July (HR 1.28; 95% CI 1.17, 1.40), August (HR 1.40; 95% CI 1.28, 1.52), September (HR 1.37; 95% CI 1.25, 1.50) and October (HR 4.63; 95% CI 2.77, 7.74). The ICU death proportion was 36.8% (95% CI: 35.5, 38.1) in alpha surge and increased significantly to 39.8 (95% CI 38.6, 41.1) in delta surge. The risk of COVID-19 death was significantly higher in delta surge compared to alpha surge (HR 1.22; 95% CI 1.17, 1.27). Delta surge was associated with a higher risk of death compared to alpha surge. High number of hospitalizations, a shortage of hospital beds, ICU spaces and medical supplies, poor nutritional status of hospitalized patients, and lack of the intensivist physicians or specialized nurses in the ICU were factors that contributed to the high mortality rate in the delta surge in Iran.

1 October 2020 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
ESEhsan Shamsi-Gooshki
Ehsan Shamsi-Gooshki
APAlireza Parsapoor
Alireza Parsapoor
FAFariba Asghari
Fariba Asghari
MPMojtaba Parsa
Mojtaba Parsa
YSYasaman Saeedinejad
Yasaman Saeedinejad
MMMostafa Moin
Mostafa Moin
Background: The medical profession has always been an inspiration for human societies throughout its diverse history. This position and historical authority in the field of ethics has had a different and higher status, in such a way that many of the norms of general ethics and professional ethics, especially principles, such as trust, confidentiality and respect for human dignity, have been developed by medical professionals. Developing guidelines of general and professional ethics is one of the inherent duties of the Medical Council of the Islamic Republic of Iran (IRIMC) as a professional organization. In this regard, the Supreme Council of IRIMC has approved the "Code of Ethics for Medical Professionals" and, in accordance with its legal authority, has annexed it to the disciplinary regulations of IRIMC. Methods: A draft document, the result of extensive literature review, was discussed in 27 expert panel meetings and after receiving and endorsing the stakeholders’ point of view, was approved by the IRIMC Supreme Council. Results: The first edition of "Code of Ethics for Medical Professionals, Medical Council of Islamic Republic of Iran" was developed on July 6, 2017 by the Supreme Council of IRIMC. The guideline was set to take effect one year after its enactment. The first edition was revised and completed and final edition was adopted on August 9, 2018 by IRIMC in 13 chapters and 140 articles (original full text is available in the Supplementary file 1). Conclusion: According to the approved decision by the Supreme Council of IRIMC on May 10, 2018, the final edition takes effect as of October 7, 2018.

28 October 2021 in Journal of Environmental Health Science and Engineering
Verified
Journal Article
Open access
PDF file
MHMostafa Hadei
Mostafa Hadei
PHPhilip K. Hopke
Philip K. Hopke
ASAbbas Shahsavani
Abbas Shahsavani
ARAlireza Raeisi
Alireza Raeisi
AJAhmad Jonidi Jafari
Ahmad Jonidi Jafari
MAMehrab Aghazadeh
Mehrab Aghazadeh
Purpose The association between air pollutant (PM2.5, PM10, NO2, and O3) concentrations and daily number of COVID-19 confirmed cases and related deaths were evaluated in three major Iranian cities (Tehran, Mashhad, and Tabriz). Methods Hourly concentrations of air pollutants and daily number of PCR-confirmed cases and deaths of COVID-19 were acquired (February 20th, 2020 to January 4th, 2021). A generalized additive model (GAM) assuming a quasi-Poisson distribution was used to model the associations in each city up to lag-day 7 (for mortality) and 14 (for morbidity). Then, the city-specific estimates were meta-analyzed using a fixed effect model to obtain the overall relative risks (RRs). Results A total of 114,964 confirmed cases and 21,549 deaths were recorded in these cities. For confirmed cases, exposure to PM2.5, NO2, and O3 for several lag-days showed significant associations. In case of mortality, meta-analysis estimated that the RRs for PM2.5, PM10, NO2, and O3 concentrations were 1.06 (95% CI: 0.99, 1.13), 1.06 (95% CI: 0.93, 1.19), 1.15 (95% CI: 0.93, 1.38), and 1.07 (95% CI: 0.84, 1.31), respectively. Despite several positive associations with all air pollutants over multiple lag-days, COVID-19 mortality was only significantly associated with NO2 on lag-days 0–1 and 1 with the RRs of 1.35 (95% CI: 1.04, 1.67) and 1.16 (95% CI: 1.02, 1.31), respectively. Conclusion This study showed that air pollution can be a factor exacerbating COVID-19 infection and clinical outcomes. Actions should be taken to reduce the exposure of the public and particularly patients to ambient air pollutants.

22 May 2021 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
SOSaeed Oraee-Yazdani
Saeed Oraee-Yazdani
MAMohammadhosein Akhlaghpasand
Mohammadhosein Akhlaghpasand
GSGelareh Shokri
Gelareh Shokri
FRFatemeh Rostami
Fatemeh Rostami
MGMaryam Golmohammadi
Maryam Golmohammadi
MSMasoud Soleimani
Masoud Soleimani